IRIS Accounts Production v24.3.0.553 07757131 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 0 0 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh077571312023-03-31077571312024-03-31077571312023-04-012024-03-31077571312022-03-31077571312022-04-012023-03-31077571312023-03-3107757131ns15:EnglandWales2023-04-012024-03-3107757131ns14:PoundSterling2023-04-012024-03-3107757131ns10:Director12023-04-012024-03-3107757131ns10:Director22023-04-012024-03-3107757131ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107757131ns10:Micro-entities2023-04-012024-03-3107757131ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3107757131ns10:FullAccounts2023-04-012024-03-3107757131ns10:RegisteredOffice2023-04-012024-03-3107757131ns5:CurrentFinancialInstruments2024-03-3107757131ns5:CurrentFinancialInstruments2023-03-31077571311ns10:Director12023-03-31077571311ns10:Director12022-03-31077571311ns10:Director12023-04-012024-03-31077571311ns10:Director12022-04-012023-03-31077571311ns10:Director12024-03-31077571311ns10:Director12023-03-31
REGISTERED NUMBER: 07757131 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

TELEMARQ LTD

TELEMARQ LTD (BY SHARES) (REGISTERED NUMBER: 07757131)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Company Information 1

Balance Sheet 2


TELEMARQ LTD (BY SHARES)

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Dr J Q Stafford-Fraser
Dr R A Melikan





REGISTERED OFFICE: Alban House
99 High Street South
Dunstable
Bedfordshire
LU6 3SF





REGISTERED NUMBER: 07757131 (England and Wales)





ACCOUNTANTS: Stoten Gillam Limited
Chartered Accountants
Alban House
99 High Street South
Dunstable
Bedfordshire
LU6 3SF

TELEMARQ LTD (BY SHARES) (REGISTERED NUMBER: 07757131)

BALANCE SHEET
31 MARCH 2024

2024 2023
£    £    £    £   
FIXED ASSETS 562 13,587

CURRENT ASSETS 115,496 99,279

PREPAYMENTS AND ACCRUED INCOME 1,498 3,238

CREDITORS
Amounts falling due within one year (67,410 ) (46,101 )
NET CURRENT ASSETS 49,584 56,416
TOTAL ASSETS LESS CURRENT
LIABILITIES

50,146

70,003

ACCRUALS AND DEFERRED INCOME 1,301 12,631
NET ASSETS 48,845 57,372

CAPITAL AND RESERVES 48,845 57,372

NOTES TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was NIL (2023 - NIL).

2. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Dr J Q Stafford-Fraser
Balance outstanding at start of year (508 ) (1,869 )
Amounts advanced 537 1,361
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 29 (508 )



TELEMARQ LTD (BY SHARES) (REGISTERED NUMBER: 07757131)

BALANCE SHEET - continued
31 MARCH 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 3 November 2024 and were signed on its behalf by:




Dr J Q Stafford-Fraser - Director



Dr R A Melikan - Director